Vizo-PF Dorzolatim preservative-free eye drops (Dorzolamide (as HCI) 20 mg/mL, Timolol (as maleate) 5 mg/mL) is a new Pharmaceutical Benefits Scheme (PBS)-listed combination drop for patients with open-angle glaucoma and ocular hypertension.
The only preservative-free glaucoma treatment available for patients in a multi-dose bottle, Vizo-PF Dorzolatim helps to reduce further irritation during their glaucoma treatment and also helps to reduce plastic waste in the environment.
Vizo-PF Dorzolatim is indicated for the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate. Before prescribing, review the full product information at aftpharm.com/prescription/vizo-pf-dorzolatim.
Contact: AFT Pharmaceuticals (AUS) 1800 238 742
PBS Information: Restricted benefit. Treatment of elevated IOP in patients with ocular hypertension or open-angle glaucoma when concomitant therapy is appropriate.
